NCT00820768View on ClinicalTrials.gov

A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

April 1, 2012

Primary Completion Date

April 1, 2013

Study Completion Date

April 1, 2014

Conditions

Solid Tumor

Interventions

DRUG

ABI-010

17-AAG and ABI-007

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY